Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474613 · ClinicalTrials.gov registry record · NA
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04474613 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 26 participants.
The verdict
NCT04474613, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if liquid biopsies will reduce time to begin treatment in participants with non-small cell lung cancer (NSCLC). A liquid biopsy is a test done on a sample of blood to look for cancer cells.
Interventions
- DIAGNOSTIC_TEST Liquid biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-08-27 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474613
The ClinicalTrials.gov registry entry for NCT04474613 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liquid biopsy is the first listed.
NCT04474613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474613 about?
NCT04474613 is a clinical study titled "Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites". The purpose of this study is to determine if liquid biopsies will reduce time to begin treatment in participants with non-small cell lung cancer (NSCLC). A liquid biopsy is a test done on a sample of blood to look for cancer cells.
What is the current status of trial NCT04474613?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2020-08-27. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT04474613?
The interventions under investigation include: Liquid biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04474613?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.